Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study.


Journal

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
ISSN: 2148-5607
Titre abrégé: Turk J Gastroenterol
Pays: Turkey
ID NLM: 9515841

Informations de publication

Date de publication:
07 2022
Historique:
entrez: 26 7 2022
pubmed: 27 7 2022
medline: 28 7 2022
Statut: ppublish

Résumé

Seroepidemiology, risk factors to hepatitis E virus exposure, and prevalence of hepatitis E virus viremia have not yet been investigated among patients under immunosuppression or with liver disease that are high risk for infection in Turkey. In this cross-sectional study, 292 consecutive serum samples from renal transplant recipients, allogeneic hematopoietic stem cell transplant recipients, patients with acute hepatitis, and patients with chronic hepatitis C were prospectively collected in a ter- tiary university hospital. Sera were tested for hepatitis E virus immunoglobulin G/immunoglobulin M and hepatitis E virus ribonucleic acid using commercial enzyme-linked immunosorbent assay and in-house nested polymerase chain reaction with Sanger sequencing, respectively. Sociodemographic, clinical, laboratory data, and risk factors were collected using a questionnaire and hospital database. Multiple logistic regression analysis was employed to identify independent predictors for anti-hepatitis E virus seropositivity. Among all patients, only 2 patients (1 renal transplant recipient and 1 patient with acute hepatitis) were identified as having hepatitis E virus genotype 3 viremia. Hepatitis E virus viremia rate was 0.6% in whole group. These patients showed no signs of chronic hepatitis E virus infection for 6 months and were spontaneously seroconverted 6 months after enrollment. Anti-hepatitis E virus IgG was positive in 29 patients yielding a hepatitis E virus seroprevalence of 9.9%. Older age (adjusted odds ratio: 1.03, 95% CI, 1.00-1.06; P = .022) and eating undercooked meat (adjusted odds ratio: 3.11, 95% CI, 1.08-8.92; P = .034) were independent risk factors to anti- hepatitis E virus seropositivity in all patients. Similarly, multiple logistic regression analysis demonstrated that age (adjusted odds ratio: 1.03, 95% CI, 0.99-1.07, P = .058) and eating undercooked meat (adjusted odds ratio: 5.77, 95% CI, 1.49-22.25, P = .011) were indepen- dent risk factors for anti-hepatitis E virus IgG positivity in the liver disease subgroup consisting of acute hepatitis and chronic hepatitis C patients. The hepatitis E virus seroprevalence rate was high (9.9%), despite low viremia rate (0.6%) in high-risk patients. The emer- gence of hepatitis E virus genotype 3 might indicate a serious problem for these patients. Future investigations are needed to elucidate foodborne transmission routes of hepatitis E virus in Turkey.

Sections du résumé

BACKGROUND
Seroepidemiology, risk factors to hepatitis E virus exposure, and prevalence of hepatitis E virus viremia have not yet been investigated among patients under immunosuppression or with liver disease that are high risk for infection in Turkey.
METHODS
In this cross-sectional study, 292 consecutive serum samples from renal transplant recipients, allogeneic hematopoietic stem cell transplant recipients, patients with acute hepatitis, and patients with chronic hepatitis C were prospectively collected in a ter- tiary university hospital. Sera were tested for hepatitis E virus immunoglobulin G/immunoglobulin M and hepatitis E virus ribonucleic acid using commercial enzyme-linked immunosorbent assay and in-house nested polymerase chain reaction with Sanger sequencing, respectively. Sociodemographic, clinical, laboratory data, and risk factors were collected using a questionnaire and hospital database. Multiple logistic regression analysis was employed to identify independent predictors for anti-hepatitis E virus seropositivity.
RESULTS
Among all patients, only 2 patients (1 renal transplant recipient and 1 patient with acute hepatitis) were identified as having hepatitis E virus genotype 3 viremia. Hepatitis E virus viremia rate was 0.6% in whole group. These patients showed no signs of chronic hepatitis E virus infection for 6 months and were spontaneously seroconverted 6 months after enrollment. Anti-hepatitis E virus IgG was positive in 29 patients yielding a hepatitis E virus seroprevalence of 9.9%. Older age (adjusted odds ratio: 1.03, 95% CI, 1.00-1.06; P = .022) and eating undercooked meat (adjusted odds ratio: 3.11, 95% CI, 1.08-8.92; P = .034) were independent risk factors to anti- hepatitis E virus seropositivity in all patients. Similarly, multiple logistic regression analysis demonstrated that age (adjusted odds ratio: 1.03, 95% CI, 0.99-1.07, P = .058) and eating undercooked meat (adjusted odds ratio: 5.77, 95% CI, 1.49-22.25, P = .011) were indepen- dent risk factors for anti-hepatitis E virus IgG positivity in the liver disease subgroup consisting of acute hepatitis and chronic hepatitis C patients.
CONCLUSION
The hepatitis E virus seroprevalence rate was high (9.9%), despite low viremia rate (0.6%) in high-risk patients. The emer- gence of hepatitis E virus genotype 3 might indicate a serious problem for these patients. Future investigations are needed to elucidate foodborne transmission routes of hepatitis E virus in Turkey.

Identifiants

pubmed: 35879919
doi: 10.5152/tjg.2022.21493
pmc: PMC9404861
doi:

Substances chimiques

Hepatitis Antibodies 0
Immunoglobulin G 0
RNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

615-624

Références

Br J Haematol. 2019 Jul;186(1):191-195
pubmed: 30768677
Blood. 2013 Aug 8;122(6):1079-86
pubmed: 23794068
J Clin Virol. 2013 Dec;58(4):629-34
pubmed: 24210958
Ann Clin Microbiol Antimicrob. 2018 May 2;17(1):17
pubmed: 29716597
Virology. 1991 Nov;185(1):120-31
pubmed: 1926770
N Engl J Med. 2008 Feb 21;358(8):811-7
pubmed: 18287603
Viruses. 2021 Apr 13;13(4):
pubmed: 33924409
J Med Virol. 2019 Dec;91(12):2174-2181
pubmed: 31403185
Transplantation. 2018 Jul;102(7):1139-1147
pubmed: 29953421
J Clin Microbiol. 2002 Sep;40(9):3209-18
pubmed: 12202555
Transfusion. 2015 Jul;55(7):1662-7
pubmed: 25819381
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
J Viral Hepat. 2021 Nov;28(11):1643-1655
pubmed: 34415657
Science. 1990 Mar 16;247(4948):1335-9
pubmed: 2107574
Gastroenterology. 2011 May;140(5):1481-9
pubmed: 21354150
Euro Surveill. 2016 Jun 29;22(26):
pubmed: 28681720
Int J Infect Dis. 2020 Feb;91:188-195
pubmed: 31756566
BMC Infect Dis. 2016 Nov 8;16(1):659
pubmed: 27825308
Viruses. 2016 Aug 06;8(8):
pubmed: 27509518
Curr Opin Virol. 2014 Feb;4:91-6
pubmed: 24513966
N Engl J Med. 2012 Sep 27;367(13):1237-44
pubmed: 23013075
Lancet. 2014 Nov 15;384(9956):1766-73
pubmed: 25078306
Transfusion. 2017 Dec;57(12):2958-2964
pubmed: 28833188
Emerg Infect Dis. 2011 Dec;17(12):2309-12
pubmed: 22172156
World J Gastroenterol. 2020 Oct 7;26(37):5543-5560
pubmed: 33071523
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
pubmed: 7984417
Liver Int. 2021 Mar;41(3):449-455
pubmed: 33034121
Gastroenterology. 2016 Feb;150(2):355-7.e3
pubmed: 26551551
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH